2026 SPONSORS

Tillotts have over 30 years’ expertise in developing and manufacturing treatments for inflammatory bowel disease (IBD). We understand the disease, treatment options and the challenges GI healthcare professionals and patients face.

Tillotts Pharma UK is a market leader in GI health products and provides support in the following areas:

• Inflammatory Bowel Disease

• Clostridioides difficile infections

Tillotts are passionate about improving patient care and supporting healthcare professionals who care for patients with diseases of the GI system. The Tillotts LOGIC Education programme offers online and face to face training and support, and our annual IBD Stars Event with the Richard Driscoll award encourages best practice sharing and recognises the achievements of IBD nurses.

Tillotts are proud to be supporting the GIN conference in 2026.

Tillotts are part of the Zeria Group. www.tillotts.co.uk

Accurx is the communication platform used by 98% of GP practices and a growing number of NHS trusts and pharmacies, helping to connect everyone involved in a patient’s care. Each week, nearly 200,000 healthcare professionals use Accurx to communicate with patients about their care. It enables staff to send SMS and email messages to patients and other healthcare providers, manage inbound demand from patients, transform outpatient care, and more. Accurx is working with nursing teams across England to implement a digital form that can improve patient access, streamline workflows, and support safer, more efficient management of patient queries.

BIOHIT Healthcare Ltd is the UK subsidiary of BIOHIT Oyj, a Finnish biotechnology company specialising in the development, manufacture and marketing of products and analysis systems for the early diagnosis and prevention of gastrointestinal diseases.
We specialise in digestive disease diagnostics, offering a portfolio of unique and patented tests designed to transform clinical practice by making screening, diagnosis and monitoring of gastrointestinal diseases more efficient and cost effective. Non-invasive diagnostics are at the core of our offering, making BIOHIT the provider of choice for leading gastroenterologists and laboratory scientists across the UK.

We’re committed to working with health professionals to ensure the highest possible standards of treatment and care for people affected by bowel cancer. We provide education resources, networking opportunities and services to support you and your patients.

We’re Crohn’s & Colitis UK and we’re changing what it means to live with these lifelong, incurable gut conditions. Around one in 120 people in the UK have Crohn’s Disease or Ulcerative Colitis, navigating life with an unpredictable condition that could flare up at any time. And the impact can be devastating: plans turned upside down; work and education on hold; relationships and wellbeing under strain; dreams for the future paused.
No one should face that alone. That’s where we come in.
We provide trusted information, support cutting-edge research and lead bold campaigns designed to get people talking about Crohn’s and Colitis like never before. We’re transforming understanding, building the recognition these conditions deserve and uniting our community to drive real change.
We’re fighting for a tomorrow where everyone living with Crohn’s or Colitis has everything they need to live well, and for a future where we don’t have to live with it at all.
Crohn’s? Colitis? We’ll face it together.

GBUK Group GBUK Group is an award-winning medical device provider, offering complete patient care from the moment of admission through to rehabilitation. GBUK Group designs, develops and distributes medical devices across enteral feeding, vascular access, patient handling and critical care environments. They are committed to the research and development of products that enable healthcare professionals to treat patients with dignity, confidence and efficiency.

Kebomed UK Ltd formed in 2005 and is a distributor of medical products, supplying a range of products from world leading manufacturers enabling us to offer a comprehensive portfolio of products for all disciplines. Kebomed focuses primarily in the following specialities: Obstetrics & Gynaecology, General Surgery, Urology and Orthopaedics as well as AMT Enteral Feeding devices and bridles. Kebomed supports its’ product portfolio with a direct, professional sales team and is part of a wider European organization in 10 countries, providing our customers and suppliers a uniformed supply chain throughout Europe. For more information about Kebomed UK Ltd please visit www.kebomed.co.uk

Lilly is the world’s largest pharmaceutical company by market cap and has a commitment to making life better for people around the world. Lilly has a major and long-term commitment to the UK with Lilly UK being our first affiliate business to open outside of the US in 1934. Our UK operations have played a central role in our company’s global development.

Stryker Surgical Technologies provides innovative solutions that help healthcare professionals operate in safer, more efficient, and more sustainable operating rooms. Our portfolio includes Neptune 3 for surgical waste management, Neptune S for waste management in the GI space, and SafeAir smoke evacuation system - all designed to enhance safety, efficiency, and sustainability in surgical environments.

Calmoseptine Inc. markets Calmoseptine Ointment in the US, Canada, Philippines, United Arab Emirates, Jordan, Malaysia, and Thailand. Calmoseptine Inc. has focused its marketing efforts toward hospitals, skilled nursing facilities and home health care agencies. Calmoseptine Inc. is securing pharmacies to stock Calmoseptine Ointment for the convenience of its loyal customers.

Calmoseptine Ointment is Calmoseptine Inc.’s sole product, which has allowed the company to be more innovative, flexible and
diverse in marketing. Health care professionals recommend Calmoseptine Ointment because of its unique properties not offered by its competitors.

Calmoseptine Ointment is an effective, multipurpose moisture barrier that protects and helps heal skin irritations.
For more information, please call us at 800-800-3405, e-mail us at info@calmoseptine.com, or visit www.calmoseptine.com.

Our study days and conference programme draws upon the wealth of knowledge and expertise of the clinical staff at The Royal Marsden, and other organisations who are leaders in their field. Education has consistently been an integral part of The Royal Marsden. Our objective has always been to promote excellence in cancer care and education, and we continue to be proactive in terms of the development of our entire educational programme. Our study days and conferences attract doctors, nurses, allied health professionals and many more, both nationally and internationally, from specialist cancer centres, general hospitals, hospices, or the community. Whether you are looking for a general overview of cancer care or specialist knowledge which will support your role, we look forward to welcoming you to The Royal Marsden.